Literature DB >> 17619898

Inter-laboratory validation of PCR-based HPV detection in pathology specimens.

Iver Petersen1, Christiane Schewe, Karsten Schlüns, Manfred Dietel, Norbert Speich, Christoph Schmitt, Magdolna Bollmann, Karl Sotlar, Burkhard Bültmann, Maria T Dours-Zimmermann, Barbara Padberg, Dieter R Zimmermann.   

Abstract

The detection and typing of human papilloma virus (HPV) in pathology specimens is gaining increasingly in importance. In the context of the initiative for quality assurance in pathology (QuIP) of the German Society of Pathology and the Professional Association of German Pathologists, four panel laboratories with experience and expertise in polymerase chain reaction (PCR)-based HPV detection were selected to establish an inter-laboratory trial. In a first step, these laboratories performed an internal testing of their own methodologies, which comprised DNA sequencing, multiplex nested PCR and hybridization techniques. Material from 39 samples including paraffin sections and DNA preparations of tissues and plasmids were evaluated by each panel institute according to their own protocols. Despite the different methodologies, a high degree of inter-laboratory reliability was achieved. In this report, we summarise the results. Pretested specimens are available for the external trail and can be ordered from the steering institute via provitro GmbH Berlin ( http://www.provitro.de ). Supplementary data are online available at http://pathologie-ccm.charite.de (rubric "Forschung"), which includes a web-based photo gallery of HPV-associated lesions and their potential association with specific virus types. The initiative is intended to foster the quality assurance of molecular HPV analysis in pathology and its correlation with morphological changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619898     DOI: 10.1007/s00428-007-0437-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  49 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Clinical relevance of human papillomavirus testing in cytopathology.

Authors:  A A T P Brink; G D Zielinski; R D M Steenbergen; P J F Snijders; C J L M Meijer
Journal:  Cytopathology       Date:  2005-02       Impact factor: 2.073

3.  Inter-laboratory validation of PCR-based detection of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissues.

Authors:  Christiane Schewe; Torsten Goldmann; Marianne Grosser; Albert Zink; Karsten Schlüns; Stefan Pahl; Timo Ulrichs; Stefan H E Kaufmann; Andreas Nerlich; Gustavo B Baretton; Manfred Dietel; Ekkehard Vollmer; Iver Petersen
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

Review 4.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

Review 5.  Molecular diagnosis of human papillomavirus (HPV) infections.

Authors:  Anco Molijn; Berhard Kleter; Wim Quint; Leen-Jan van Doorn
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

6.  Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Authors:  M H Schiffman; N B Kiviat; R D Burk; K V Shah; R W Daniel; R Lewis; J Kuypers; M M Manos; D R Scott; M E Sherman
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

8.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

9.  Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia.

Authors:  Oliver Brummer; Bettina Hollwitz; Gerd Böhmer; Henning Kühnle; K Ulrich Petry
Journal:  Gynecol Oncol       Date:  2006-02-17       Impact factor: 5.482

10.  Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery.

Authors:  H J Huang; S L Huang; C Y Lin; R W Lin; F Y Chao; M Y Chen; T C Chang; S Hsueh; K H Hsu; C H Lai
Journal:  Int J Gynecol Cancer       Date:  2004 Jul-Aug       Impact factor: 3.437

View more
  12 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

Review 2.  [Diagnosis and differential diagnosis of cervical adenocarcinoma].

Authors:  T Löning; L Riethdorf; M Köbel
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

Authors:  Matthias Choschzick; Linn Woelber; Stephan Hess; Christine zu Eulenburg; Jörg Schwarz; Ronald Simon; Sven Mahner; Fritz Jaenicke; Volkmar Müller
Journal:  Virchows Arch       Date:  2010-04-01       Impact factor: 4.064

4.  Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.

Authors:  Stefan Huttenlocher; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Christoph Thorns; Katrin Hasselbacher; Barbara Wollenberg; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

5.  Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.

Authors:  D Rades; N D Seibold; S E Schild; K L Bruchhage; M P Gebhard; F Noack
Journal:  Strahlenther Onkol       Date:  2013-10       Impact factor: 3.621

6.  Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.

Authors:  N D Seibold; S E Schild; M P Gebhard; F Noack; U Schröder; D Rades
Journal:  Strahlenther Onkol       Date:  2013-05-24       Impact factor: 3.621

7.  Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  D Rades; N D Seibold; A Hoffmann; M P Gebhard; F Noack; C Thorns; S E Schild
Journal:  Strahlenther Onkol       Date:  2013-07-17       Impact factor: 3.621

8.  Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  D Rades; N D Seibold; M P Gebhard; F Noack; K L Bruchhage; S E Schild
Journal:  Strahlenther Onkol       Date:  2013-07-18       Impact factor: 3.621

Review 9.  [HPV in non-gynecological tumors].

Authors:  I Petersen; F Klein
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

10.  Is human papillomavirus associated with prostate cancer survival?

Authors:  Mariarosa Pascale; Danae Pracella; Renzo Barbazza; Barbara Marongiu; Enrico Roggero; Serena Bonin; Giorgio Stanta
Journal:  Dis Markers       Date:  2013-10-30       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.